SCHEMBL5540753

SCHEMBL5540753

CC(C)(C)C(=O)N1CCC(NS(=O)(=O)C(C)(C)C)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
NPY5R Q15761 1/20 0.36
EPHX2 P34913 3/20 0.36
CXCR3 P49682 1/20 0.36
WNT3 P56703 1/20 0.34
SFRP1 Q8N474 1/20 0.34
EPHX1 P07099 3/20 0.34
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2754308 0.87 DPP4 (0.39) ALDH1A1NPY5REPHX2EPHX1LMNA
SCHEMBL2980571 0.85 ALDH1A1 (0.38) ALDH1A1NPY5REPHX2WNT3SFRP1
SCHEMBL24435818 0.85 EPHX2 (0.50) ALDH1A1EPHX2EPHX1MEN1KMT2A
SCHEMBL11923033 0.85 ALDH1A1 (0.41) ALDH1A1DRD2DRD4DRD3EPHX2
SCHEMBL10133512 0.83 CCR8 (0.41) ALDH1A1NPY5REPHX2EPHX1LMNA
SCHEMBL10115727 0.81 LMNA (0.47) ALDH1A1EPHX2EPHX1LMNANPSR1
SCHEMBL10265588 0.81 DRD2 (0.39) ALDH1A1DRD2DRD4DRD3EPHX2
SCHEMBL16591620 0.80 BTK (0.40) ALDH1A1DRD2DRD4DRD3EPHX2
SCHEMBL10115725 0.77 LMNA (0.57) ALDH1A1EPHX2EPHX1LMNASMN1; SMN2
SCHEMBL21133374 0.77 ALDH1A1 (0.46) ALDH1A1DRD2DRD4DRD3EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed